{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:28:36Z","timestamp":1791347316887,"version":"4.3.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T00:00:00Z","timestamp":1302480000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0018358","type":"journal-article","created":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T20:53:31Z","timestamp":1302555211000},"page":"e18358","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Geographic Differences in Time to Culture Conversion in Liquid Media: Tuberculosis Trials Consortium Study 28. Culture Conversion Is Delayed in Africa"],"prefix":"10.1371","volume":"6","clinical-trial-number":[{"clinical-trial-number":"nct00144417","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"William R.","family":"Mac Kenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Heilig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Bozeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Muzanye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Metchock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Eisenach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Dorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,4,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/ajrccm\/147.4.1062","article-title":"Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months.","volume":"147","author":"DA Mitchison","year":"1993","journal-title":"American Review of Respiratory Disease"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1086\/517133","article-title":"Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis.","volume":"26","author":"EE Telzak","year":"1998","journal-title":"Clinical Infectious Diseases"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1742-1241.2006.01131.x","article-title":"Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis.","volume":"61","author":"M Guler","year":"2007","journal-title":"International Journal of Clinical Practice"},{"key":"ref4","first-page":"20","article-title":"Pulmonary tuberculosis and diabetes Retrospective study of 60 patients in Tunisia.","volume":"38","author":"S Maalej","year":"2009","journal-title":"Presse Medicale"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4269\/ajtmh.2009.80.634","article-title":"Impact of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis.","volume":"80","author":"KE Dooley","year":"2009","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"ref6","first-page":"1070","article-title":"Characteristics associated with reported sputum culture conversion in the era of re-emergent Mycobacterium tuberculosis in the State of North Carolina, 1993-1998.","volume":"7","author":"HM Salihu","year":"2003","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.rmed.2004.08.016","article-title":"Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis.","volume":"99","author":"AT Abal","year":"2005","journal-title":"Respiratory Medicine"},{"key":"ref8","first-page":"1049","article-title":"Tobacco and tuberculosis: a qualitative systematic review and meta-analysis.","volume":"11","author":"K Slam","year":"2007","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1164\/rccm.200901-0078OC","article-title":"Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis.","volume":"180","author":"SE Dorman","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.200603-360OC","article-title":"Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.","volume":"174","author":"WJ Burman","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/AAC.00353-10","article-title":"Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations.","volume":"54","author":"M Weiner","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref12","first-page":"553","article-title":"A class of rank test procedures for censored survival -data Biometrika","volume":"69","author":"DP Harrington","year":"1982"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","article-title":"Diagnostic standards and classification of tuberculosis in adults and children.","volume":"161","author":"NE Dunlap","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"ref14","article-title":"Laboratory Services in Tuberculosis Control.","year":"1998"},{"key":"ref15","first-page":"381","article-title":"Rapid detection and simultaneous strain differentiation of Mycobacterium tuberculosis complex bacteria by spoligotyping.","volume":"101","author":"BA Molhuizen HOF","year":"1998","journal-title":"Methods Mol Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JCM.42.1.474-477.2004","article-title":"Transfer of a Mycobacterium tuberculosis genotyping method, spoligotyping, from a reverse line-blot hybridization, membrane-based assay to the Luminex multianalyte profiling system.","volume":"42","author":"LS Cowan","year":"2004","journal-title":"Journal of Clinical Microbiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JCM.43.2.688-695.2005","article-title":"Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the United States.","volume":"43","author":"LS Cowan","year":"2005","journal-title":"Journal of Clinical Microbiology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.31.2.406-409.1993","article-title":"Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.","volume":"31","author":"CM van Embden JDA","year":"1993","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0041-3879(56)80187-6","article-title":"A comparison of acute extensive pulmonary tuberculosis and its response to chemotherapy in Britain and Uganda.","volume":"37","author":"HP Fox W","year":"1956","journal-title":"Tubercle"},{"key":"ref20","first-page":"452","article-title":"Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.","volume":"126","author":"VVB Rekha","year":"2007","journal-title":"Indian Journal of Medical Research"},{"key":"ref21","article-title":"Laboratory Detection and Identification of Mycobacteria; Approved Guideline.","author":"CLSI","year":"2008"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0732-8893(03)00138-X","article-title":"Evaluation of sputum decontamination methods for Mycobacterium tuberculosis using viable colony counts and flow cytometry.","volume":"47","author":"TVN Burdz","year":"2003","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"ref23","first-page":"1572","article-title":"Comparison of two concentrations of NALC-NaOH for decontamination of sputum for mycobacterial culture.","volume":"13","author":"RL Peres","year":"2009","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2741\/1291","article-title":"Persistent and dormant tubercle bacilli and latent tuberculosis.","volume":"9","author":"Y Zhang","year":"2004","journal-title":"Frontiers in Bioscience"},{"key":"ref25","first-page":"128","article-title":"A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.","volume":"12","author":"R Rustomjee","year":"2008","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"ref26","first-page":"528","article-title":"Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.","volume":"4","author":"ML Joloba","year":"2000","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1164\/rccm.200904-0536OC","article-title":"Shortening Treatment in adults with noncavitary tuberculosis and 2-month culture conversion.","volume":"180","author":"J Johnson","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(09)60333-0","article-title":"Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.","volume":"373","author":"MB Conde","year":"2009","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0018358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T04:21:52Z","timestamp":1592454112000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0018358"}},"subtitle":[],"editor":[{"given":"Madhukar","family":"Pai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,11]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0018358","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,11]]}}}